Identification
- Summary
Sodium glycerophosphate is a medication used to treat hypophosphatemia.
- Brand Names
- Glycophos, Olimel, Periolimel
- Generic Name
- Sodium glycerophosphate
- DrugBank Accession Number
- DB09561
- Background
Sodium glycerophosphate is one of several glycerophosphate salts. It is used clinically to treat or prevent low phosphate levels Label. Glycerophosphate is hydrolyzed to inorganic phosphate and glycerol in the body 1. The extent of this reaction is dependent on the activity of serum alkaline phosphatases.
- Type
- Small Molecule
- Groups
- Approved
- Structure
- Weight
- Average: 216.036
Monoisotopic: 215.9775635 - Chemical Formula
- C3H7Na2O6P
- Synonyms
- Disodium glycerol phosphate
- Sodium glycerophosphate anhydrous
Pharmacology
- Indication
Sodium glycerophosphate is indicated for use as a source of phosphate in total parenteral nutrition Label. It is used in combination with amino acids, dextrose, lipid emulsions, and other electrolytes.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Therapies
- Contraindications & Blackbox Warnings
- Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.
- Pharmacodynamics
Glycerophosphate acts as a source of inorganic phosphate through hydrolysis 1.
- Mechanism of action
Sodium glycerophosphate acts as a donor of inorganic phosphate 1. See Monopotassium phosphate for a description of phosphate's role in the body.
- Absorption
Peak serum phosphate concentration is reached in 4h 1.
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
Glycerophosphate is hydrolyzed to form inorganic phosphate 1. The extent of this reaction is dependent on serum alkaline phosphatase activity.
- Route of elimination
Inorganic phosphate produced is eliminated in the urine 1. There may be a very small amount of glycerophosphate excreted in the urine unchanged.
- Half-life
Inorganic phosphate has a half-life of elimination of 2.06h 1.
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Product Ingredients
Ingredient UNII CAS InChI Key Sodium glycerophosphate hydrate RCS9EQ01V4 55073-41-1 OFNNKPAERNWEDD-UHFFFAOYSA-L - Active Moieties
Name Kind UNII CAS InChI Key Sodium cation ionic LYR4M0NH37 17341-25-2 FKNQFGJONOIPTF-UHFFFAOYSA-N - International/Other Brands
- Glycophos (Fresenius Kabi Norge)
- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Glycophos Injection, solution 216 mg/1mL Intravenous Fresenius Kabi USA, LLC 2013-05-13 Not applicable US - Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml Injection 216 mg/ml Intravenous FRESENIUS KABI (SINGAPORE) PTE LTD 2002-01-04 Not applicable Singapore - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image AMINOMIX 1 INTRAVENÖZ İNZFÜZYON, 1000 ML Sodium glycerophosphate (4.59 g/500mL) + Acetic acid (4.5 g/500mL) + Alanine (7 g/500mL) + Arginine (6 g/500mL) + Calcium chloride (0.294 g/500mL) + D-glucose monohydrate (200 g/500mL) + Glycine (5.5 g/500mL) + Histidine (1.5 g/500mL) + Isoleucine (2.5 g/500mL) + Leucine (3.7 g/500mL) + Lysine hydrochloride (3.3 g/500mL) + Magnesium chloride hexahydrate (0.61 g/500mL) + Methionine (2.15 g/500mL) + Phenylalanine (2.55 g/500mL) + Potassium chloride (1.47 g/500mL) + Proline (5.6 g/500mL) + Serine (3.25 g/500mL) + Sodium chloride (1.169 g/500mL) + Taurine (0.5 g/500mL) + Threonine (2.2 g/500mL) + Tryptophan (1 g/500mL) + Tyrosine (0.2 g/500mL) + Valine (3.1 g/500mL) + Zinc chloride (5.45 mg/500mL) Injection, solution Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 2019-07-16 Turkey AMINOMIX 1 INTRAVENÖZ İNZFÜZYON, 1500 ML Sodium glycerophosphate (4.59 g/500mL) + Acetic acid (4.5 g/500mL) + Alanine (7 g/500mL) + Arginine (6 g/500mL) + Calcium chloride (0.294 g/500mL) + D-glucose monohydrate (200 g/500mL) + Glycine (5.5 g/500mL) + Histidine (1.5 g/500mL) + Isoleucine (2.5 g/500mL) + Leucine (3.7 g/500mL) + Lysine hydrochloride (3.3 g/500mL) + Magnesium chloride hexahydrate (0.61 g/500mL) + Methionine (2.15 g/500mL) + Phenylalanine (2.55 g/500mL) + Potassium chloride (1.47 g/500mL) + Proline (5.6 g/500mL) + Serine (3.25 g/500mL) + Sodium chloride (1.169 g/500mL) + Taurine (0.5 g/500mL) + Threonine (2.2 g/500mL) + Tryptophan (1 g/500mL) + Tyrosine (0.2 g/500mL) + Valine (3.1 g/500mL) + Zinc chloride (5.45 mg/500mL) Injection, solution Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 2019-07-16 Turkey AMINOMIX 1 INTRAVENÖZ İNZFÜZYON, 2000 ML Sodium glycerophosphate (4.59 g/500mL) + Acetic acid (4.5 g/500mL) + Alanine (7 g/500mL) + Arginine (6 g/500mL) + Calcium chloride (0.294 g/500mL) + D-glucose monohydrate (200 g/500mL) + Glycine (5.5 g/500mL) + Histidine (1.5 g/500mL) + Isoleucine (2.5 g/500mL) + Leucine (3.7 g/500mL) + Lysine hydrochloride (3.3 g/500mL) + Magnesium chloride hexahydrate (0.61 g/500mL) + Methionine (2.15 g/500mL) + Phenylalanine (2.55 g/500mL) + Potassium chloride (1.47 g/500mL) + Proline (5.6 g/500mL) + Serine (3.25 g/500mL) + Sodium chloride (1.169 g/500mL) + Taurine (0.5 g/500mL) + Threonine (2.2 g/500mL) + Tryptophan (1 g/500mL) + Tyrosine (0.2 g/500mL) + Valine (3.1 g/500mL) + Zinc chloride (5.45 mg/500mL) Injection, solution Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 2019-07-16 Turkey Aminomix 1 Novum - Infusionslösung Sodium glycerophosphate (4.59 g/L) + Acetic acid (4.5 g/L) + Alanine (7 g/L) + Arginine (6 g/L) + Calcium chloride (0.294 g/L) + D-glucose monohydrate (220 g/L) + Glycine (5.5 g/L) + Histidine (1.5 g/L) + Hydrochloric acid (1.47 ml/L) + Isoleucine (2.5 g/L) + Leucine (3.7 g/L) + Lysine hydrochloride (4.125 g/L) + Magnesium chloride hexahydrate (0.61 g/L) + Methionine (2.15 g/L) + Phenylalanine (2.55 g/L) + Potassium hydroxide (1.981 g/L) + Proline (5.6 g/L) + Serine (3.25 g/L) + Sodium chloride (1.169 g/L) + Taurine (0.5 g/L) + Threonine (2.2 g/L) + Tryptophan (1 g/L) + Tyrosine (0.2 g/L) + Valine (3.1 g/L) + Zinc chloride (0.00545 g/L) Solution Intravenous Fresenius Kabi Austria Gmb H 2005-12-05 Not applicable Austria AMINOMIX 1 NOVUM 1500 ML Sodium glycerophosphate (4.59 g/500mL) + Acetic acid (4.5 g/500mL) + Alanine (7 g/500mL) + Arginine (6 g/500mL) + Calcium chloride (0.294 g/500mL) + D-glucose monohydrate (200 g/500mL) + Glycine (5.5 g/500mL) + Histidine (1.5 g/500mL) + Isoleucine (2.5 g/500mL) + Leucine (3.7 g/500mL) + Lysine hydrochloride (3.3 g/500mL) + Magnesium chloride hexahydrate (0.61 g/500mL) + Methionine (2.15 g/500mL) + Phenylalanine (2.55 g/500mL) + Potassium chloride (1.47 g/500mL) + Proline (5.6 g/500mL) + Serine (3.25 g/500mL) + Sodium chloride (1.169 g/500mL) + Taurine (0.5 g/500mL) + Threonine (2.2 g/500mL) + Tryptophan (1 g/500mL) + Tyrosine (0.2 g/500mL) + Valine (3.1 g/500mL) + Zinc chloride (5.45 mg/500mL) Injection, solution Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey AMINOMIX 1 NOVUM IV INFUZYON ICIN STERIL APIROJEN COZELTI 2000 ML Sodium glycerophosphate (4.59 g/500mL) + Acetic acid (4.5 g/500mL) + Alanine (7 g/500mL) + Arginine (6 g/500mL) + Calcium chloride (0.294 g/500mL) + D-glucose monohydrate (200 g/500mL) + Glycine (5.5 g/500mL) + Histidine (1.5 g/500mL) + Isoleucine (2.5 g/500mL) + Leucine (3.7 g/500mL) + Lysine hydrochloride (3.3 g/500mL) + Magnesium chloride hexahydrate (0.61 g/500mL) + Methionine (2.15 g/500mL) + Phenylalanine (2.55 g/500mL) + Potassium chloride (1.47 g/500mL) + Proline (5.6 g/500mL) + Serine (3.25 g/500mL) + Sodium chloride (1.169 g/500mL) + Taurine (0.5 g/500mL) + Threonine (2.2 g/500mL) + Tryptophan (1 g/500mL) + Tyrosine (0.2 g/500mL) + Valine (3.1 g/500mL) + Zinc chloride (5.45 mg/500mL) Injection, solution Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey AMINOMIX 1 NOVUM IV INFUZYON ICIN STERIL APIROJEN COZELTI,1000 ML Sodium glycerophosphate (4.59 g/500mL) + Acetic acid (4.5 g/500mL) + Alanine (7 g/500mL) + Arginine (6 g/500mL) + Calcium chloride (0.294 g/500mL) + D-glucose monohydrate (200 g/500mL) + Glycine (5.5 g/500mL) + Histidine (1.5 g/500mL) + Isoleucine (2.5 g/500mL) + Leucine (3.7 g/500mL) + Lysine hydrochloride (3.3 g/500mL) + Magnesium chloride hexahydrate (0.61 g/500mL) + Methionine (2.15 g/500mL) + Phenylalanine (2.55 g/500mL) + Potassium chloride (1.47 g/500mL) + Proline (5.6 g/500mL) + Serine (3.25 g/500mL) + Sodium chloride (1.169 g/500mL) + Taurine (0.5 g/500mL) + Threonine (2.2 g/500mL) + Tryptophan (1 g/500mL) + Tyrosine (0.2 g/500mL) + Valine (3.1 g/500mL) + Zinc chloride (5.45 mg/500mL) Injection, solution Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey Aminomix 2 Novum - Infusionslösung Sodium glycerophosphate (4.59 g/L) + Acetic acid (4.5 g/L) + Alanine (7 g/L) + Arginine (6 g/L) + Calcium chloride (0.294 g/L) + Dextrose, unspecified form (120 g/L) + Glycine (5.5 g/L) + Histidine (1.5 g/L) + Hydrochloric acid (1.47 ml/L) + Isoleucine (2.5 g/L) + Leucine (3.7 g/L) + Lysine hydrochloride (4.125 g/L) + Magnesium chloride hexahydrate (0.61 g/L) + Methionine (2.15 g/L) + Phenylalanine (2.55 g/L) + Potassium hydroxide (1.981 g/L) + Proline (5.6 g/L) + Serine (3.25 g/L) + Sodium chloride (1.169 g/L) + Taurine (0.5 g/L) + Threonine (2.2 g/L) + Tryptophan (1 g/L) + Tyrosine (0.2 g/L) + Valine (3.1 g/L) + Zinc chloride (0.00545 g/L) Solution Intravenous Fresenius Kabi Austria Gmb H 2005-12-05 Not applicable Austria AMINOMIX 2 NOVUM 1000 ML Sodium glycerophosphate (4.59 g/500mL) + Acetic acid (4.5 g/500mL) + Alanine (7 g/500mL) + Arginine (6 g/500mL) + Calcium chloride (0.294 g/500mL) + D-glucose monohydrate (120 g/500mL) + Glycine (5.5 g/500mL) + Histidine (1.5 g/500mL) + Isoleucine (2.5 g/500mL) + Leucine (3.7 g/500mL) + Lysine hydrochloride (3.3 g/500mL) + Magnesium chloride hexahydrate (0.61 g/500mL) + Methionine (2.15 g/500mL) + Phenylalanine (2.55 g/500mL) + Potassium chloride (1.47 g/500mL) + Proline (5.6 g/500mL) + Serine (3.25 g/500mL) + Sodium chloride (1.169 g/500mL) + Taurine (0.5 g/500mL) + Threonine (2.2 g/500mL) + Tryptophan (1 g/500mL) + Tyrosine (0.2 g/500mL) + Valine (3.1 g/500mL) + Zinc chloride (5.45 mg/500mL) Injection, solution Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey AMINOMIX 2 NOVUM 1500 ML Sodium glycerophosphate (4.59 g/500mL) + Acetic acid (4.5 g/500mL) + Alanine (7 g/500mL) + Arginine (6 g/500mL) + Calcium chloride (0.294 g/500mL) + D-glucose monohydrate (120 g/500mL) + Glycine (5.5 g/500mL) + Histidine (1.5 g/500mL) + Isoleucine (2.5 g/500mL) + Leucine (3.7 g/500mL) + Lysine hydrochloride (3.3 g/500mL) + Magnesium chloride hexahydrate (0.61 g/500mL) + Methionine (2.15 g/500mL) + Phenylalanine (2.55 g/500mL) + Potassium chloride (1.47 g/500mL) + Proline (5.6 g/500mL) + Serine (3.25 g/500mL) + Sodium chloride (1.169 g/500mL) + Taurine (0.5 g/500mL) + Threonine (2.2 g/500mL) + Tryptophan (1 g/500mL) + Tyrosine (0.2 g/500mL) + Valine (3.1 g/500mL) + Zinc chloride (5.45 mg/500mL) Injection, solution Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Glycophos Sodium glycerophosphate (216 mg/1mL) Injection, solution Intravenous Fresenius Kabi USA, LLC 2013-05-13 Not applicable US GLYCOPHOSE IV INFUZYON ICIN STERIL APIROJEN SOLUSYON 10X20 ML FLAKON Sodium glycerophosphate hydrate (216 mg) Solution Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey KABIVEN 1026 ML Sodium glycerophosphate (1.5 g) + Alanine (4.8 g) + Arginine (3.4 g) + Aspartic acid (1 g) + Calcium chloride dihydrate (0.29 g) + D-glucose monohydrate (110 g) + Glutamic acid (1.7 g) + Glycine (2.4 g) + Histidine (2 g) + Isoleucine (1.7 g) + Leucine (2.4 g) + Lysine (2.7 g) + Magnesium sulfate heptahydrate (0.99 g) + Methionine (1.7 g) + Phenylalanine (2.4 g) + Potassium chloride (1.8 g) + Proline (2 g) + Serine (1.4 g) + Sodium acetate trihydrate (2.5 g) + Soybean oil (40 g) + Threonine (1.7 g) + Tryptophan (0.57 g) + Tyrosine (0.07 g) + Valine (2.2 g) Injection Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey KABIVEN 1540 ML Sodium glycerophosphate (2.3 g) + Alanine (7.2 g) + Arginine (5.1 g) + Aspartic acid (1.5 g) + Calcium chloride dihydrate (0.44 g) + D-glucose monohydrate (165 g) + Glutamic acid (2.5 g) + Glycine (3.6 g) + Histidine (3.1 g) + Isoleucine (2.5 g) + Leucine (3.6 g) + Lysine (4.1 g) + Magnesium sulfate heptahydrate (1.5 g) + Methionine (2.5 g) + Phenylalanine (3.6 g) + Potassium chloride (2.7 g) + Proline (3.1 g) + Serine (2 g) + Sodium acetate trihydrate (3.7 g) + Soybean oil (60 g) + Threonine (2.5 g) + Tryptophan (0.86 g) + Tyrosine (0.1 g) + Valine (3.3 g) Injection Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey KABIVEN 2053 ML Sodium glycerophosphate (3 g) + Alanine (9.6 g) + Arginine (6.8 g) + Aspartic acid (2 g) + Calcium chloride dihydrate (0.59 g) + D-glucose monohydrate (220 g) + Glutamic acid (3.4 g) + Glycine (4.7 g) + Histidine (4.1 g) + Isoleucine (3.4 g) + Leucine (4.7 g) + Lysine (5.4 g) + Magnesium sulfate heptahydrate (2 g) + Methionine (3.4 g) + Phenylalanine (4.7 g) + Potassium chloride (3.6 g) + Proline (4.1 g) + Serine (2.7 g) + Sodium acetate trihydrate (4.9 g) + Soybean oil (80 g) + Threonine (3.4 g) + Tryptophan (1.1 g) + Tyrosine (0.14 g) + Valine (4.4 g) Injection Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey KABIVEN PERIPHERAL 1440 ML Sodium glycerophosphate (1.5 g) + Alanine (4.8 g) + Arginine (3.4 g) + Aspartic acid (1 g) + Calcium chloride dihydrate (0.29 g) + D-glucose monohydrate (107 g) + Glutamic acid (1.7 g) + Glycine (2.4 g) + Histidine (2 g) + Isoleucine (1.7 g) + Leucine (2.4 g) + Lysine (2.7 g) + Magnesium sulfate heptahydrate (0.99 g) + Methionine (1.7 g) + Phenylalanine (2.4 g) + Potassium chloride (1.8 g) + Proline (2 g) + Serine (1.4 g) + Sodium acetate trihydrate (2.5 g) + Soybean oil (51 g) + Threonine (1.7 g) + Tryptophan (0.57 g) + Tyrosine (0.069 g) + Valine (2.2 g) Injection Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey KABIVEN PERIPHERAL 1920 ML Sodium glycerophosphate (2 g) + Alanine (6.4 g) + Arginine (4.5 g) + Aspartic acid (1.4 g) + Calcium chloride dihydrate (0.39 g) + D-glucose monohydrate (143 g) + Glutamic acid (2.2 g) + Glycine (3.2 g) + Histidine (2.7 g) + Isoleucine (2.2 g) + Leucine (3.2 g) + Lysine (3.6 g) + Magnesium sulfate heptahydrate (1.3 g) + Methionine (2.2 g) + Phenylalanine (3.2 g) + Potassium chloride (2.4 g) + Proline (2.7 g) + Serine (1.8 g) + Sodium acetate trihydrate (3.3 g) + Soybean oil (68 g) + Threonine (2.2 g) + Tryptophan (0.76 g) + Tyrosine (0.092 g) + Valine (2.9 g) Injection Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey
Categories
- ATC Codes
- B05XA14 — Sodium glycerophosphate
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as glycerophosphates. These are compounds containing a glycerol linked to a phosphate group.
- Kingdom
- Organic compounds
- Super Class
- Lipids and lipid-like molecules
- Class
- Glycerophospholipids
- Sub Class
- Glycerophosphates
- Direct Parent
- Glycerophosphates
- Alternative Parents
- Alkyl phosphates / Secondary alcohols / 1,2-diols / Primary alcohols / Organic sodium salts / Organic oxides / Hydrocarbon derivatives
- Substituents
- 1,2-diol / Alcohol / Aliphatic acyclic compound / Alkyl phosphate / Hydrocarbon derivative / Organic alkali metal salt / Organic oxide / Organic oxygen compound / Organic phosphoric acid derivative / Organic salt
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- G43E72677U
- CAS number
- 1334-74-3
- InChI Key
- GEKBIENFFVFKRG-UHFFFAOYSA-L
- InChI
- InChI=1S/C3H9O6P.2Na/c4-1-3(5)2-9-10(6,7)8;;/h3-5H,1-2H2,(H2,6,7,8);;/q;2*+1/p-2
- IUPAC Name
- disodium 3-(phosphonooxy)propane-1,2-diol
- SMILES
- [Na+].[Na+].OCC(O)COP([O-])([O-])=O
References
- General References
- Topp H, Hochfeld O, Bark S, Grossmann M, Joukhadar C, Westphal M, Straatsma H, Rothenburger M: Glycerophosphate is interchangeable with inorganic phosphate in terms of safety and serum pharmacokinetics. Pharmacology. 2011;88(3-4):193-200. doi: 10.1159/000331341. Epub 2011 Oct 4. [Article]
- External Links
- PubChem Compound
- 22251426
- PubChem Substance
- 347827880
- ChemSpider
- 14071
- 1595589
- ChEMBL
- CHEMBL3040581
- FDA label
- Download (806 KB)
- MSDS
- Download (46.7 KB)
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Terminated Supportive Care Cancer-related Malnutrition 1 4 Terminated Supportive Care Critically Ill Patients 1 4 Unknown Status Diagnostic Hypophosphatemia 1 4 Withdrawn Supportive Care Malnutrition 1 3 Active Not Recruiting Supportive Care Critically Ill Patients / Nutritional supplementation 1 3 Completed Treatment Parenteral Feedings / Surgery 1 3 Completed Treatment Parenteral Nutrition / Surgery 1 3 Completed Treatment Parenting 2 3 Terminated Treatment Pancreatic Cancer 1 Not Available Completed Treatment Haematological Malignancies 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intravenous Injection, solution Intramuscular Syrup Oral Tablet Oral Injection Intravenous Injection, solution Intravenous 216 mg/1mL Solution Intravenous 216 mg/1ml Injection, solution, concentrate Intravenous Injection Intravenous 216 mg/ml Injection, solution Intravenous Solution Intravenous 216 mg Injection, emulsion Intravenous Injection Intravenous Injection Intravenous 1.6 g/l Injection, emulsion Parenteral Emulsion Intravenous Injection, emulsion; injection, solution Intravenous Solution Intravenous Emulsion Intravenous 4 g Emulsion Intravenous 3 g Emulsion Parenteral Liquid Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
Property Value Source water solubility Soluble MSDS - Predicted Properties
Property Value Source Water Solubility 81.5 mg/mL ALOGPS logP -1.4 ALOGPS logP -2 Chemaxon logS -0.42 ALOGPS pKa (Strongest Acidic) 1.51 Chemaxon pKa (Strongest Basic) -3 Chemaxon Physiological Charge -2 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 112.88 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 29.15 m3·mol-1 Chemaxon Polarizability 12.87 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
Drug created at November 30, 2015 19:10 / Updated at February 13, 2021 11:02